B.1 Original articles
B.1. Articles published
1. E Avrahami, VE Drory, MJ Rabey, DF Cohn
Generalized epileptic seizures as the presenting symptom of lacunar infarction in the brain
J. Neurol., Vol 235, 1988 (pp. 472-474)
2. VE Drory, MY Neufeld, E Avrahami, AD Korczyn
Serial EEG recordings following intrathecal metrizamide administration
Clin. Electroencephalogr, Vol 20, 1989 (pp. 202-208)
3. VE Drory, E Avrahami, MY Neufeld, AD Korczyn
EEG recordings following intrathecal Iohexol administration
Clin. Neuropharmacol., Vol 13, 1990 (pp.318-321)
4. VE Drory, AD Korczyn
Apparent placebo effect in epilepsy
New Trends Clin. Neuropharmacol., Vol 5, 1991 (pp.49-56)
5. VE Drory, MJ Rabey, DF Cohn
Electrophysiologic features in patients with chronic neurolathyrism
Acta Neurol. Scand., Vol 85, 1992 (pp.401-403)
6. VE Drory, AD Korczyn
Sympathetic skin response: age effect
Neurology, Vol 43, 1993 (pp.1818-1820)
7. VE Drory, MY Neufeld, AD Korczyn
F-wave characteristics following acute and chronic upper motor neuron lesions
Electromyogr. Clin. Neurophysiol., Vol 33, 1993 (pp. 441-446)
8. VE Drory, AD Korczyn
The sympathetic skin response in reflex sympathetic dystrophy
J. Neurol. Sci., Vol 128, 1995 (pp. 92-95)
9. VE Drory, P Nisipeanu, AD Korczyn
Tests of autonomic dysfunction in patients with multiple sclerosis
Acta Neurol. Scand., Vol. 92, 1995 (pp. 356-360)
10. MY Neufeld, VE Drory, AD Korczyn
Duration and factors affecting electroencephalogram slowing after generalized tonic-clonic seizures
J. Epilepsy, Vol. 8, 1995 (pp. 193-196)
11. VE Drory, R Inzelberg, GB Groozman, AD Korczyn
N30 somatosensory evoked potentials in patients with unilateral Parkinson’s disease
Acta Neurol. Scand., Vol. 97, 1998 (pp.73-76)
12. VE Drory, D Lev, GB Groozman, M Gutman, JN Klausner
Neurotoxicity of isolated limb perfusion with tumor necrosis factor
J. Neurol. Sci., Vol. 158, 1998 (pp. 1-4)
13. VE Drory, A Shapira, AD Korczyn, S Shavit, M Kushnir, DM Michaelson, J Chapman
Antineurofilament antibodies in post-polio-syndrome
Neurology, Vol. 51, 1998 (pp. 1193-1195)
14. VE Drory, GB Groozman, A Rubinstein, AD Korczyn
Hypertriglyceridemia may cause a subclinical peripheral neuropathy
Electromyogr. Clin. Neurophysiol., Vol. 39, 1999 (pp. 39-41)
15. N Giladi, ES Simon, AD Korczyn, GB Groozman, Y Orlov, H Shabtai, VE Drory
Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson’s disease
Muscle Nerve, Vol. 23, 2000 (pp.731-734)
16. O. Hilkevich, VE Drory, J Chapman, AD Korczyn
The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis
Clin. Neuropharmacol., Vol. 24, 2001 (pp. 173-176)
17. VE Drory, M Birnbaum, AD Korczyn, J Chapman
Association of APOE e4 allele with survival in amyotrophic lateral sclerosis
J. Neurol. Sci., Vol. 190, 2001 (pp.17-20)
18. VE Drory, E Goltsman, JG Reznik, A Mosek, AD Korczyn
The value of muscle exercise in patients with amyotrophic lateral sclerosis
J. Neurol. Sci., Vol. 191, 2001 (pp. 133-137)
19. VE Drory, I. Kovach, GB Groozman
Electrophysiologic evaluation of upper motor neuron involvement in amyotrophic lateral sclerosis
Amyotroph Lateral Scler Other Motor Neuron Disord, Vol. 2, 2001 (pp. 147-152)
20. M Kafri, VE Drory, N Wang, R Rabinovich, AD Korczyn, J Chapman
Assessment of autoimmune neuritis in the rat by electrophysiology of the tail nerve
Muscle Nerve, Vol. 25, 2002 (pp. 51-57)
21. VE Drory, D Gross
No effect of creatine on respiratory distress in amyotrophic lateral sclerosis
Amyotroph Lateral Scler Other Motor Neuron Disord, Vol. 3, 2002 (pp. 43-46)
22. VE Drory, M Birnbaum, L Peleg, B Goldman, AD Korczyn
Hexosaminidase A deficiency is an uncommon cause of a syndrome mimicking amyotrophic lateral sclerosis
Muscle Nerve, Vol. 28, 2003 (pp. 109-112)
23. TY Gurevich, GB Groozman, N Giladi, VE Drory, JM Hausdorff, AD Korczyn
R-R interval variation in Parkinson’s disease and multiple system atrophy
Acta Neurol Scand, Vol. 109, 2004 (pp. 276-279)
24. M Kafri, Y Kloog, AD Korczyn, R Ferdman-Aronovich, VE Drory, A Katzav, I Wirguin, J Chapman
Inhibition of Ras attenuates the course of experimental autoimmune neuritis
J. Neuroimmunol, Vol. 168, 2005 (pp. 46-55)
25. M Rabie, VE Drory
A test for the evaluation of the lateral cutaneous branch of the iliohypogastric nerve using somatosensory evoked potentials.
J. Neurol. Sci., Vol. 238, 2005 (pp. 59-63)
26. D Paran, J Chapman, AD Korczyn, O Elkayam, O Hilkevich, GB Groozman, D Levartovsky, I Litinsky, D Caspi, Y Segev, VE Drory
Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis
Ann. Rheum. Dis., Vol. 65, 2006 (pp. 525-528)
27. SM Albert, M Wasner, T Tider, VE Drory, GD Borasio
Cross-cultural variation in mental health at end of life in patients with ALS
Neurology, Vol. 68, 2007 (pp.1058-1061)
28. VE Drory, GB Groozman
Value of repeat electromyographic studies in patients with stable lumbar radiculopathies
J. Back Musculoskeletal Rehab., Vol. 20, 2007 (pp. 37-42)
29. VE Drory, I Artamonov
Earlier onset and shorter survival of amyotrophic lateral sclerosis in Jewish patients of North African origin. A clue to modifying genetic factors?
J. Neurol. Sci., Vol. 258, 2007 (pp. 39-43)
30. S Rochkind, VE Drory, M Alon, M Nissan, GE Ouaknine
Laser phototherapy (780 nm), a new modality in treatment of long-term incomplete peripheral nerve injury: a randomized double-blind placebo-controlled study
Photomedicine and Laser Surgery, Vol. 25, 2007 (pp. 436-442)
31. E Shavit, O Beilin, AD Korczyn, C Sylantiev, R Aronovich, VE Drory, D Gurwitz, I Horresh, R Bar-Shavit, E Peles, J Chapman
Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block
Brain, Vol. 131, 2008 (pp. 1113-1122)
32. VE Drory, T Bronipolsky, I Artamonov, B Nefussy
Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis
J. Neurol. Sci., Vol. 273, 2008 (pp. 81-83)
33. D Keizman, O Rogowski, S Berliner, M Ish-Shalom, N Maimon, B Nefussy, I Artamonov, VE Drory
Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis
Acta Neurol Scand, Vol. 119, 2009 (pp. 383-389)
34. N Vaisman, M Lusaus, B Nefussy, E Niv, D Comaheshter, R Hallack, VE Drory
Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?
J. Neurol. Sci., Vol. 279, 2009 (pp. 26-29)
35. A Kesler, V Vakchapova, AD Korczyn, VE Drory
Visual evoked potentials in idiopathic intracranial hypertension
Clin Neurol Neurosurg, Vol. 111, 2009 (pp. 433-436)
36. V Meininger, VE Drory, PN Leigh, A Ludolph, W Robberecht, V Silani
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double-blind, randomized, multicentre, placebo-controlled trial
Amyotroph Lateral Scler Vol. 10, 2009 (pp. 378-383)
37. SC Blumen, VE Drory, M Sadeh, B El-Ad, U Soimu, GB Groozman, JP Bouchard, LG Goldfarb
Mutational analysis of glycyl-tRNA synthetase (GARS) gene in Hirayama disease
Amyotroph Lateral Scler Vol. 11, 2010 (pp. 237-239)
38. B Nefussy, I Artamonov, V Deutsch, E Naparstek, A Nagler, VE Drory
Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study
Amyotroph Lateral Scler Vol. 11, 2010 (pp. 187-193)
39. SC Blumen, JP Bouchard, B Brais, RL Carasso, D Paleacu, VE Drory, S Chantal, N Blumen, I Braverman
Cognitive impairment and reduced life span of oculoparyngeal muscular dystrophy homozygotes
Neurology, Vol. 73, 2009 (pp. 596-601)
40. D Keizman, M Ish-Shalom, S Berliner, N Maimon, Y Vered, I Artamonov, J Tsehori, B Nefussy, VE Drory
Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?
J Neurol Sci, Vol. 285, 2009 (pp. 95-99)
41. B Kandinov, AD Korczyn, R Rabinowitz, B Nefussy, VE Drory
Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis
Aut Neurosci, Vol. 159, 2011 (pp. 84-89)
42. B Nefussy, J Hirsch, ME Cudkowicz, VE Drory
Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis
J Neurol Sci, Vol. 300, 2011 (pp. 23-27)
43. D Ben Bashat, M Artzi, R Tarrasch, B Nefussy, VE Drory, O Aizenstein
A potential tool for the diagnosis of ALS based on diffusion tensor imaging
Amyotroph Lateral Scler, Vol. 12, 2011 (pp.398-405)
44. B Kandinov, VE Drory, K Tordjman, AD Korczyn
Blood pressure measurements in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis
Amyotroph Lateral Scler, Vol. 13, 2012 (pp.509-513)
45. VE Drory, T Bronipolsky, V Bluvshtein, A Catz, AD Korczyn
Occurrence of fatigue over 20 years after recovery from Guillain-Barre syndrome
J Neurol Sci, Vol. 316, 2012 (pp.72-75)
46. E Majounie, AE Renton, K Mok, EGP Dopper, A Waite, S Rollinson, A Chio, G Restagno, N Nicolaou, J Simon-Sanchez, JC van Swieten, Y Abramzon, JO Johnson, M Sendtner, R Pamphlett, RW Orrell, S Mead, KC Sidle, H Houlden, JD Rohrer, KE Morrison, H Pall, K Talbot, O Ansorge, The Chromosome 9-ALS/FTD Consortium, The French research network on FTLD/ALS, The ITALSGEN Consortium, DG Hernandez, S Arepalli, M Sabatelli, G Mora, M Corbo, F Giannini, A Calvo, E Englund, G Borghero, GL Floris, AM Remes, H Laaksovirta, L McCluskey, JO Trojanowski, VM van Deerlin, GD Schellenberg, MA Nalls, VE Drory, CS Lu, TH Yeh, H Ishiura, Y Takahashi, S Tsuji, I LeBer, A Brice, C Drepper, N Williams, J Kirby, P Shaw, J Hardy, PJ Tienari, P Heutink, HR Morris, S Pickering-Brown, BJ Traynor Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and fronto-temporal dementia: a cross-sectional study
Lancet Neurol, Vol. 11, 2012 (pp. 323-330)
47. CH Wu, C Fallini, N Ticozzi, P Keagle, PC Sapp, K Piotrowska, P Lowe, M Koppers, D McKenna-Yasek, D Baron, JE Kost, P Gonzalez-Perez P, AD Fox, J Adams, F Taroni, C Tiloca, AL Leclerc, SC Chafe, D Mangroo, MJ Moore, JA Zitzewitz, Z Xu, LH van den Berg, JD Glass, G Siciliano, T Cirulli, DB Goldstein, F Salachas, V Meininger, W Rossoll, A Ratti, C Gellera, DA Bosco, GJ Bassell, V Silani, VE Drory, RH Brown, JE Landers.
Mutations in the Profilin 1 gene cause familial amyotrophic lateral sclerosis
Nature, Vol. 488 (7412), 2012 (pp.499-503)
48. P González-Pérez, ET Cirulli, VE Drory, R Dabby, P Nisipeanu, RL Carasso, M Sadeh, A Fox, BW Festoff, PC Sapp, D McKenna-Yasek, DB Goldstein, RH Brown, SC Blumen
Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis
Neurology, Vol. 79, 2012 (pp. 2201-2208)
49. M Edri-Brami, B Rosental, D Hayoun, M Welt, H Rosen, I Wirguin, B Nefussy, VE Drory, A Porgador, RG Liechtenstein
Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells
PLoS ONE, Vol. 7, 2012; e35772
50. S Kolusheva, R Yossef, A Kugel, M Katz, R Volinsky, U Hadad, V Drory, M Kliger, E Rubin, A Porgador, R Jelinek, M Welt
Array-based disease diagnostics using lipid/polydiacetylene vesicles encapsulated in a sol-gel matrix
Anal Chem, Vol. 84, 2012 (pp.5925-5931)
51. SC Blumen, A Kesler, R Dabby, S Shalev, M Khayat, Y Almog, J Zoldan, F Benninger, VE Drory, M Gurevich, M Sadeh, B Brais, I Braverman
Oculopharyngeal muscular dystrophy among Bulgarian Jews. A new cluster?
Isr Med Assoc J, Vol. 15, 2013 (pp. 748-752)
52. B Kandinov, NC Grigoriadis, O Touloumi, VE Drory, D Offen, AD Korczyn
Immunohistochemical analysis reveals sympathetic column involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis
Amyotroph Lateral Scler Frontotemp Degener, Vol. 14, 2013 (pp. 424-433)
53. A Abraham, VE Drory
Postradiation lower motor neuron syndrome: case series and literature review.
J Neurol, Vol. 260, 2013 (pp. 1802-1806)
54. M Sarfaty, B Nefussy, D Gross, Y, Shapira, N Vaisman, VE Drory
Outcome of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis in relation to respiratory dysfunction.
Amyotroph Lateral Scler Frontotemp Degener, Vol. 14, 2013 (pp. 528-532)
55. A. Abraham, M. Gotkine, VE Drory, SC Blumen
Effect of neck flexion on somatosensory and motor evoked potentials in Hirayama disease
J Neurol Sci, Vol. 334, 2013 (pp. 102-105)
56. P Liu, V Gelowani, F Zhang, VE Drory, S Ben-Shachar, E Roney, AC Medeiros, RJ Moore, C DiVincenzo, WB Burnette, JJ Higgins, J Li, A Orr Urtreger, JR Lupski
Mechanism, prevalence, and more severe neuropathy phenotype of the Charcot-Marie-Tooth type 1A triplication
Am J Hum Genet, Vol. 94, 2014 (pp. 462-469)
57. JO Johnson, EP Pioro, A Boehringer, R Chia, H Feit, AE Renton, HA Pliner, Y Abramzon, G Marangi, BJ Winborn, JR Gibbs, MA Nalls, S Morgan, J Hardy, A Pittman, RW Orrell, A Malaspina, KC Sidle, P Fratta, MB Harms, RH Baloh, A Pestronk, CC Weihl, E Rogaeva, L Zinman, VE Drory, G Borghero, G Mora, A Calvo, JD Rothstein, ITALSGEN, C Drepper, M Sendtner, AB Singleton, JP Taylor, MR Cookson, G Restagno, M Sabatelli, R Bowser, A Chio, BJ Traynor Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis
Nature Neuroscience, Vol. 17, 2014 (pp. 664-666)
58. A Abraham, VE Drory
Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis.
J Neurol, Vol. 261, 2014 (pp. 1133-1138)
59. A Abraham, VE Drory
Listening to music during EMG does not influence the examinee's anxiety and pain levels
Muscle Nerve, Vol. 50, 2014 (pp. 445-447)
60. M Gotkine, A Abraham, VE Drory, Z Argov, M Gomori, SC Blumen
Dynamic MRI testing of the cervical spine has prognostic significance in patients with progressive upper-limb distal weakness and atrophy
J Neurol Sci, Vol. 345, 2014 (pp. 168-171)
61. JO Johnson, S Glynn, RJ Gibbs, MA Nalls, M Sabatelli, G Restagno, VE Drory, A Chio, E Rogaeva, BJ Traynor
Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis
Brain, Vol.137, 2014 (pp. e311, 1-2)
62. A Gadoth, B Nefussy, M Bleiberg, T Klein, I Artmann, VE Drory
Transglutaminase 6 antibodies in the serum of patients with amyotrophic lateral sclerosis.
JAMA Neurology 2015 (in press)
B.2. Case reports
B.2. Case reports published
1. VE Drory, I Yust, AD Korczyn
Carbamazepine-induced systemic lupus erythematosus
Clin. Neuropharmacol., Vol 12, 1989 (pp. 115-118)
2. VE Drory, MY Neufeld, AD Korczyn
Carpal tunnel syndrome: a complication of idiopathic torsion dystonia
Mov Disord, Vol 6, 1991 (pp. 82-84)
3. VE Drory, P Nisipeanu
Aseptic meningitis: an unusual presentation of multiple sclerosis
Eur. Neurology, Vol 35, 1995 (pp. 240-241)
4. VE Drory, I. Sidi, AD Korczyn
Riluzole-induced pancreatitis
Neurology, Vol 52, 1999 (pp. 892-893)
5. C Sylantiev, N Schoenfeld, R Mamet, GB Groozman, VE Drory
Acute neuropathy mimicking porphyria induced by aminolevulinic acid during photodynamic therapy
Muscle Nerve (Case of the Month), Vol 31, 2005 (pp. 390-393)
6. SC Blumen, R Inzelberg, P Nisipeanu, RL Carasso, D Oved, O Aizenstein, VE Drory, C Bergstrom, PM Andersen
Aggressive familial ALS with unusual brain MRI and a SOD1 gene mutation
Amyotroph Lateral Scler Vol. 11, 2010 (pp. 228-231)
7. F Fahoum, VE Drory, J Issakov, MY Neufeld
Neurosarcoidosis presenting as Guillain-Barre-like syndrome. A case report and review of the literature
J Clin Neuromuscul Dis, Vol 11, 2009 (pp. 35-43)
8. A Abraham, S Ziv, VE Drory
Posterior reversible encephalopathy syndrome resulting from Guillain Barre like syndrome secondary to West nile virus infection
J Clin Neuromusc Dis, Vol 13, 2011 (pp. 113-117)
B.3. Review articles
B.3. Review articles published
1.VE Drory, AD Korczyn
Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants
Clin. Neuropharmacol., Vol 16, 1993 (pp. 19-29)
2. B Nefussy, VE Drory
Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies
EPMA Journal, Vol. 1, 2010 (pp. 329-341)
3. A Abraham, VE Drory
Fatigue in motor neuron diseases
Neuromusc Disord, Vol. 22, 2012 (S198-S202)
C. Chapters in books
1. VE Drory
Sympathetic skin response
In: AD Korczyn (ed.), Handbook of Autonomic Nervous System, Marcel Dekker Inc., 1995, pp. 509-522.
2. AD Korczyn and VE Drory
Electrophysiologic evaluation of cranial nerves
In: Recent advances in clinical neurophysiology, Excerpta Medica International Congress Series 1101, Elsevier, North Holland, 1996, pp. 616-619.
3. VE Drory
Riluzole and newer therapies in amyotrophic lateral sclerosis
In: L Battistin and AD Korczyn (eds.), European Society for Clinical Neuropharmacology, International Proceedings. Monduzzi Editore, 2000, pp. 133-138.
4. B Nefussy, VE Drory
Toward a personalized approach in amyotrophic lateral sclerosis: new developments in diagnosis, genetics, pathogenesis and therapies
In: S Mandel (ed.), Neurodegenerative diseases: integrative PPPM approach as the medicine of the future. Springer, 2013, pp. 205-233
D.1 Invited papers in scientific meetings
1. VE Drory
Sympathetic skin response
Symposium on Clinical Neurophysiology, Tel-Aviv, Israel, 1995
2. VE Drory
ALS management in Israel: a multidisciplinary approach
Symposium on ALS/MND, Herzlia, Israel, 1998
3. VE Drory
Treatment of experimental autoimmune neuritis by a RAS inhibitor,
Tel-Aviv University Research Fair, Tel-Aviv, Israel, 1999
4. VE Drory
Riluzole and newer therapies in ALS
5th Congress of the European Society for Clinical Neuropharmacology, Opatija, Croatia, 2000
5. VE Drory
ALS from the physician’s point of view: disease progression and the role of palliative care
Meeting of the Israel Association of Palliative Care, Ramat-Gan, Israel, 2001
6. VE Drory
Use of electromyography in the diagnosis and treatment of gastrointestinal motility dysfunction
Meeting of the Israel Society for Neurogastroenterology and Gastrointestinal Motility, Ramat-Gan, Israel, 2002
7. VE Drory
ALS FRS and measurements of effects of exercise
World Federation of Neurology Research Group on Motor Neuron Diseases, Milan, Italy, 2003
8. VE Drory
Ethnic differences in the natural history of amyotrophic lateral sclerosis in Israel
First national symposium on amyotrophic lateral sclerosis, Tel-Aviv, Israel, 2004
9. VE Drory, S Albert, G Borasio
Multinational comparison of mental health and quality of life in ALS patients approaching the end of life
Second national symposium on amyotrophic lateral sclerosis, Tel-Aviv, Israel, 2005
10. VE Drory
Emerging therapies for ALS
Israeli society for neuromuscular disorders, Herzlia, Israel, 2006
11. D Keizman and VE Drory
Evidence for systemic microinflammation in patients with ALS
Third Israeli medical conference on ALS research, Tel-Aviv, Israel, 2006
12. VE Drory
Peripheral pain syndromes
Third annual update symposium series on clinical neurology and neurophysiology, Tel-Aviv, Israel, 2007
13. VE Drory
Use of Riluzole in amyotrophic lateral sclerosis – the pros
First Conference on Neurology, Tel-Aviv, Israel, 2007
14. VE Drory
Motor neuron disorders
Fourth annual update symposium series on clinical neurology and neurophysiology, Tel-Aviv, Israel, 2008
15. VE Drory
Evoked potentials for the assessment of multiple sclerosis
Fourth annual update symposium series on clinical neurology and neurophysiology, Tel-Aviv, Israel, 2008
16. VE Drory
Palliative treatment of ALS
14th Annual Meeting of the palliative care organization “Tmicha”, Airport City, Israel, 2009
17. VE Drory
Diagnostic management of diabetic peripheral neuropathies
Annual Meeting of the Israeli Diabetic Foot Society. Ramat-Gan, Israel, 2009
18. VE Drory
Fatigue in motor neuron diseases
Satellite meeting to 12th International Congress on Neuromuscular Diseases, Pisa, Italy, 2010
19. VE Drory
Electrophysiological methods in the diagnosis of sexual dysfunction
Meeting of the Israeli Society of Sexual Dysfunction, Tel-Aviv, Israel, 2011
D.3. Papers presented at scientific meetings published as abstracts
1. AD Korczyn, VE Drory
Placebo effect of anticonvulsants in epileptic patients
Neurology, Vol 38 (Suppl 1), 1988 (p. 154)
2. VE Drory, E Avrahami, MY Neufeld, AD Korczyn
Serial EEG recordings following intrathecal administration of iohexol as compared to metrizamide
Electroencephalogr. Clin. Neurophysiol., Vol 73, 1989 (p. 36P).
3. I Yust, VE Drory, AD Korczyn
Carbamazepine-induced SLE
Neurology, Vol 40 (Suppl 1), 1990 (p. 137)
4. E Avrahami, VE Drory, MY Neufeld, AD Korczyn
Intrathecal iohexol is not encephalopathic but metrizamide is
Neurology, Vol 40 (Suppl 1), 1990 (p.148)
5. VE Drory, JM Rabey, DF Cohn
Electrodiagnostic findings in patients with chronic neurolathyrism
Neurology, Vol 40 (Suppl 1), 1990 (p. 430)
6. VE Drory, AD Korczyn
Carpal tunnel syndrome in patients with idiopathic torsion dystonia
Movement Disorders, Vol 5 (Suppl 1), 1990 (p. 98)
7. VE Drory, MY Neufeld, AD Korczyn
F-wave characteristics in the acute stage of upper motor neuron (UMN) lesions
Neurology, Vol 41 (Suppl 1), 1991 (p. 220)
8. VE Drory, MY Neufeld, AD Korczyn
F-wave changes following acute and chronic upper motor neuron lesions
Electroencephalogr. Clin. Neurophysiol., Vol 83, 1992 (p.6P-7P)
9. VE Drory, AD Korczyn
Sympathetic skin response: age effect
Ann. Neurol., Vol 32, 1992 (p. 255)
10. VE Drory, MY Neufeld, AD Korczyn
Duration and factors affecting postictal EEG slowing following generalized tonic- clonic seizures of unknown origin
Electroencephalogr. Clin. Neurophysiol., Vol 87, 1993 (p.94S)
11. P Nisipeanu, VE Drory, AD Korczyn
Sympathetic skin response: a sensitive test in patients with multiple sclerosis
Electroencephalogr. Clin. Neurophysiol., Vol 87, 1993 (p. 119S)
12. P Nisipeanu, VE Drory, MY Neufeld, AD Korczyn
Headache, transient neurological deficits and CSF pleocytosis: an underdiagnosed benign syndrome
Can. J. Neurol. Sci., Vol 20 (Suppl. 4), 1993 (p. 36S)
13. MY Neufeld, VE Drory, AD Korczyn
Factors affecting duration of postictal EEG slowing after generalized tonic-clonic seizures of unknown origin in adults
Epilepsia, Vol 34 (Suppl. 2), 1993 (p. 98)
14. VE Drory, AD Korczyn
The sympathetic skin response in reflex sympathetic dystrophy
Electroencephalogr. Clin. Neurophysiol., Vol 91, 1994 (p. 131P)
15. VE Drory, AD Korczyn
The sympathetic skin response in reflex sympathetic dystrophy
J. Neurol., Vol. 241 (Suppl. 1), 1994 (p. S121)
16. GB Groozman, VE Drory, P Nisipeanu, AD Korczyn
Effect of body cooling in patients with multiple sclerosis. A clinical and electrophysiological study
J. Neuroimmunol., Vol. 57 (Suppl. 1), 1995 (p. 65)
17. VE Drory, PF Nisipeanu, AD Korczyn
Tests of autonomic dysfunction in patients with multiple sclerosis
J. Neuroimmunol., Vol. 57 (Suppl. 1), 1995 (p. 65)
18. VE Drory, D Lev, GB Groozman, S Abu-Abid, JN Klausner
Neurotoxicity of isolated limb perfusion with tumor necrosis factor
Electroencephalogr. Clin. Neurophysiol., Vol. 95, 1995 (p. 81P)
19. P Nisipeanu, VE Drory, GB Groozman, AD Korczyn
Effect of body cooling in patients with multiple sclerosis. A clinical and electrophysiological study.
Electroencephalogr. Clin. Neurophysiol., Vol. 97, 1995 (p. S99)
20. D Lev, VE Drory, GB Groozman, S Abu-Abid, JN Klausner
Neurotoxicity of isolated limb perfusion with tumor necrosis factor
Electroencephalogr. Clin. Neurophysiol., Vol. 97, 1995 (p. S139)
21. F Bokstein, VE Drory, M Sadeh, S Pollak-Charcon, AD Korczyn
Muscle pseudohypertrophy in a patient with distal myopathy and rimmed vacuoles
Electroencephalogr. Clin. Neurophysiol., Vol. 97, 1995 (p. S215)
22. VE Drory, PF Nisipeanu, AD Korczyn
Tests of autonomic dysfunction in patients with multiple sclerosis
Electroencephalogr. Clin. Neurophysiol., Vol. 97, 1995 (p. S252)
23. D Lev, VE Drory, G Groozman, J Klausner
Electrophysiologic studies following isolated limb perfusion with tumor necrosis factor
Neurology, Vol. 46, p. 1996 (p. A232)
24. VE Drory, GB Groozman, A Rubinstein, AD Korczyn
Electrophysiologic studies in patients with hypertriglyceridemia
Neurology, Vol. 46, 1996 (p. A352)
25. VE Drory, R Inzelberg, GB Groozman, AD Korczyn
N30 somatosensory evoked potential in patients with unilateral Parkinson’s disease
Movement Disorders, Vol. 11, 1996 (p. 67)
26. M Sadeh, VE Drory, Z Argov
Single fiber EMG in Lambert-Eaton myasthenic syndrome
Electroencephalogr. Clin. Neurophysiol., Vol. 99, 1996 (p. 14P)
27. VE Drory, R Inzelberg, GB Groozman, AD Korczyn
N30 somatosensory evoked potential in patients with unilateral Parkinson’s disease
Electroencephalogr. Clin. Neurophysiol., Vol. 99, 1996 (p. 15P)
28. VE Drory, R Inzelberg, GB Groozman, AD Korczyn
N30 somatosensory evoked potential in patients with unilateral Parkinson’s disease
Electroencephalogr. Clin. Neurophysiol., Vol. 99, 1996 (p. 353)
29. VE Drory, J Chapman, A Shapira, S Shavit, M Kushnir, DM Michaelson
Antineural antibodies in patients with post-polio-syndrome, as compared to stable poliomyelitis survivors, patients with amyotrophic lateral sclerosis and controls
Neurology, Vol. 48, 1997 (p. A227)
30. E Orlov, GB Groozman, N Giladi, VE Drory, ES Simon, H Shabtai, AD Korczyn
Electromyography of the anal sphincter in parkinsonism
Neurology, Vol. 50, 1998 (p. A132)
31. VE Drory, GB Groozman
Blink reflex recovery curves in essential tremor
Electroencephalogr. Clin. Neurophysiol., Vol. 106, 1998 (p. 4P)
32. VE Drory, GB Groozman, A Rubinstein, AD Korczyn
Hypertriglyceridemia is a cause of subclinical peripheral neuropathy
Electroencephalogr. Clin. Neurophysiol., Vol. 107, 1998 (p. 37P)
33. O Hilkevich, VE Drory, J Chapman, AD Korczyn
Treatment and maintenance of myasthenia gravis with intravenous immunoglobulins
Ann. Neurol., Vol. 44, 1998 (p. 502)
34. I. Kovach, GB Groozman, VE Drory, AD Korczyn
Electrophysiologic evaluation of upper motor neuron involvement in amyotrophic lateral sclerosis
Clin. Neurophysiol., Vol. 110, 1999 (p. 2284)
35. I Kovach, GB Groozman, VE Drory, AD Korczyn
Electrophysiological evaluation of upper motor neuron involvement in amyotrophic lateral sclerosis
Ann. Neurol., Vol. 46, 1999 (p. 461)
36. I Kovach, GB Groozman, VE Drory, AD Korczyn
Electrophysiologic evaluation of upper motor neuron involvement in amyotrophic lateral sclerosis
Clin. Neurophysiol., Vol 110 (Suppl. 1), 1999 (p. S 198)
36. M Birnbaum, VE Drory, J Chapman, AD Korczyn
Apolipoprotein Ee4 genotype in amyotrophic lateral sclerosis
Neurology, Vol. 54 (Suppl. 3), 2000 (p. A341)
37. M Birnbaum, VE Drory, J Chapman, AD Korczyn
Apolipoprotein Ee4 genotype in amyotrophic lateral sclerosis
J. Neurol., Vol. 247 (Suppl. 3), 2000 (p. III/23)
39. D Gross, VE Drory
An open trial of creatine on the pulmonary function of patients with advanced amyotrophic lateral sclerosis
J. Neurol., Vol. 247 (Suppl. 3), 2000 (p. III/24)
40. M Kafri, VE Drory, I Wirguin, N Wang, Y Kloog, AD Korczyn, J Chapman
Treatment of experimental autoimmune neuritis by a Ras inhibitor, S-farnesylthiosalicylic acid (FTS)
J. Neurol., Vol. 247 (Suppl. 3), 2000 (p. III/64)
41. GB Groozman, M Zaretzky, VE Drory, J Chapman, O Hilkevich, AD Korczyn
Electrophysiological correlates of disability in multiple sclerosis
J. Neurol., Vol. 247 (Suppl. 3), 2000 (p. III/115)
42. VE Drory, M Birnbaum, AD Korczyn
Influence of smoking on the incidence and progression of amyotrophic lateral sclerosis
J. Neurol., Vol. 247 (Suppl. 3), 2000 (p. III/167)
43. L Peleg, M Birnbaum, VE Drory, AD Korczyn
Hexosaminidase A mutations in Israeli ALS patients
J. Neurol., Vol. 247 (Suppl. 3), 2000 (p. III/167)
44. VE Drory, M Alon, M Khaigrecht, GE Ouaknine, S Rochkind
Double-blind, placebo-controlled study of low-power laser therapy on incomplete peripheral nerve injuries
Ann. Neurol., Vol. 48, 2000 (p. 453)
45. GB Groozman, M Zaretzky, O Hilkevitch, J Chapman, AD Korczyn, VE Drory
Electrophysiological correlates of clinical disability in multiple sclerosis
Ann. Neurol., Vol. 48, 2000 (p. 448)
46. M Kafri, VE Drory, N Wang, Y Kloog, AD Korczyn, J Chapman
Treatment of experimental autoimmune neuritis by a Ras inhibitor S-Farnesylthiosalicylic acid
Ann. Neurol., Vol. 48, 2000 (p. 449)
47. VE Drory, D Gross
Creatine does not improve the pulmonary function of patients with advanced amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 1, Suppl. 3, 2000 (p.50-51)
48. VE Drory, E Goltsman, J Reznick
The value of muscle exercise in patients with amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 1, Suppl. 3, 2000 (p.52)
49. VE Drory, M Birnbaum, AD Korczyn
Influence of smoking on the incidence and progression of amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 1, Suppl. 3, 2000 (p.56)
50. T Gurevich, GB Groozman, N Giladi, VE Drory, J Hausdorff, AD Korczyn
R-R interval variation in Parkinson’s disease and multiple system atrophy
Neurology, Vol. 56, Suppl. 3, 2001 (p. A444)
51. VE Drory, E Goltsman, J Goldman-Reznick, A Mosek
The value of muscle exercise in patients with amyotrophic lateral sclerosis
J. Neurol. Sci., Vol. 187, Suppl., 2001 (p. S125)
52. VE Drory, J Chapman, O Hilkevich, GB Groozman, AD Korczyn
Somatosensory evoked responses are a sensitive measure of disease progression in multiple sclerosis
J. Neurol. Sci., Vol. 187, Suppl., 2001 (p. S341)
53. VE Drory, M Birnbaum, L Peleg, B Goldman, AD Korczyn
Mutations in the Hexosaminidase A gene in Israeli patients with amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 2, Suppl. 2, 2001 (p. 127)
54. M Zaretzky, GB Groozman, J Chapman, O Hilkevich, VE Drory, AD Korczyn
Sequential somatosensory evoked responses as a measure of disease progression in multiple sclerosis
Clin. Neurophysiol., Vol. 113, 2002 (p. 174)
55. J Chapman, VE Drory, AD Korczyn, O Elkayam, D Levartovsky, I Litinsky, D Caspi, Y Segev, D Paran
Evoked potentials help differentiate white matter lesions in the antiphospholipid syndrome from multiple sclerosis
Neurology, Vol. 60, Suppl. 1, 2003 (p. A486-487)
56. M Rabie, VE Drory
A novel electrophysiologic technique for testing the iliohypogastric nerve
Neurology, Vol. 60, Suppl. 1, 2003 (p. A349)
57. VE Drory, N Scheinfeld, C Sylantiev, GB Groozman
Acute polyneuropathy induced by aminolevulinic acid
J. Neurology, Vol.250, Suppl. 2, 2003 (p. P444)
58. M Rabie, VE Drory
A novel electrophysiologic technique for testing the iliohypogastric nerve
Eur. J. Neurol., Vol. 10, Suppl. 1, 2003 (p. 42)
59. VE Drory, GB Groozman
Repeat electromyographic studies in stable chronic lumbar radiculopathies
Muscle Nerve, Vol. 28, Suppl. 12, 2003 (p. S7)
60. VE Drory
Earlier age at onset of ALS in Jewish patients of North African origin
Amyotr. Later. Scler., Vol. 4, Suppl. 1, 2003 (p. 110-111)
61. O Beilin, C Sylantiev, AD Korczyn, R Aronovich, VE Drory, D Gurwitz, R Bar-Shavit, J Chapman
Protease activated receptor (PAR) mediated thrombin inhibition of sciatic nerve conduction
Neurology, Vol. 62, Suppl. 5, 2004 (p. A341)
62. VE Drory, GB Groozman
Value of repeat electromyographic studies in clinically stable chronic lumbar radiculopathies
Neurology, Vol. 62, Suppl. 5, 2004 (p. A455)
63. SC Blumen, GB Groozman, VE Drory
Somatosensory evoked potentials and transcranial magnetic stimulation findings during neck flexion and extension in patients with bilateral Hirayama disease
Eur. J. Neurol., Vol. 11, Suppl. 2, 2004 (p. 160)
64. SM Albert, VE Drory, G Borasio
Cross-national investigation of ALS and mental health at the end of life
Amyotr. Later. Scler., Vol. 5, Suppl. 2, 2004 (p. 133)
65. VE Drory
Earlier age at onset and shorter survival of amyotrophic lateral sclerosis in Jewish patients of North African origin
Neurology, Vol. 64, Suppl. 1, 2005 (p. A205)
66. GB Groozman, VE Drory
Measurements of fatigue in patients with autoimmune polyneuropathies
Neurology, Vol. 64, Suppl. 1, 2005 (p. A373-374)
67. SC Blumen, A Reches, Z Argov, M Sadeh, B El-Ad, Y Balash, GB Groozman, VE Drory
Clinical characteristics of a large non-Asian cohort of benign distal amyotrophy of the upper limbs (Hirayama disease)
Neurology, Vol. 64, Suppl. 1, 2005 (p. A205)
68. SC Blumen, GB Groozman, Y Balash, A Reches, Z Argov, M Sadeh, B El-Ad, VE Drory
Somatosensory evoked potentials and transcranial magnetic stimulation findings during neck flexion and extension in patients with bilateral Hirayama disease
Neurology, Vol. 64, Suppl. 1, 2005 (p. A292-293)
69. I Artmonov, VE Drory
Benign distal amyotrophy of upper limbs following central nervous system injury – an unusual late complication of trauma
J. Neurol., Vol. 252, Suppl. 2, 2005 (p. II/136)
70. A Kesler, V Vakhapova, AD Korczyn, V Drory
Visual evoked potentials (VEP) in idiopathic intracranial hypertension (IIH)
Eur. J. Neurol., Vol. 12, Suppl. 2, 2005 (p. 266)
71. VE Drory
Non-linear behaviour of the ALS-FRS in ALS patients toward the end of life
Amyotr. Later. Scler., Vol. 6, Suppl. 1, 2005 (p.136)
72. I Artmonov, VE Drory
Signs of sensory dysfunction in patients with amyotrophic lateral sclerosis
J. Neurol., Vol. 253, Suppl. 2, 2006 (p. II/98)
73. H Gotshal, T Gurevich, VE Drory, Y Segev, AD Korczyn
Isolated hypoglossal nerve palsy due to glomus jugulare tumor – a case report
J. Neurol., Vol. 253, Suppl. 2, 2006 (p. II/63)
74. VE Drory, D Keizman, S Berliner
Evidence for systemic inflammation in patients with advanced as compared to mild amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 7, Suppl. 1, 2006 (p.165)
75. VE Drory, I Artmonov, B Nefussy
Evaluation of treatment with rasagiline in patients with amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 8, Suppl. 1, 2007 (p.145)
76. VE Drory, V Nudelman, B Nefussy, R Rabinowitz, C Pick, AD Korczyn
The influence of central and peripheral trauma on the onset of disease and survival in a mouse model of amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 8, Suppl. 1, 2007 (p.170)
77. VE Drory, V Nudelman, B Nefussy, R Rabinowitz, C Pick, AD Korczyn
The influence of head, neck and limb trauma on the onset of disease and survival in a mouse model of amyotrophic lateral sclerosis
Neurology, Vol. 70, Suppl. 1, 2008 (p. A32-33)
78. D Keizman, O Rogowski, S Berliner, M Ish-Shalom, N Maimon, D Gross, B Nefussy, I Artmonov, Y Tsehori, VE Drory
Systemic low-grade inflammation in patients with amyotrophic lateral sclerosis
Neurology, Vol. 70, Suppl. 1, 2008 (p. A194)
79. VE Drory, T Bronipolsky, I Artamonov, N Tichmanovich, B Nefussy
Amyotrophic lateral sclerosis and statin use
Neurology, Vol. 70, Suppl. 1, 2008 (p. A343-344)
80. B Nefussy, I Artamonov, A Nagler, V Deutsh, E Naparstek, VE Drory
Granulocyte colony-stimulating factor administration in amyotrophic lateral sclerosis: a phase I/IIa, double-blind, randomized, placebo-controlled clinical trial
Amyotr. Later. Scler., Vol. 9, Suppl. 1, 2008 (p. 60)
81. J Shefner, V Meininger, J Rothstein, A Chio, A Ludolph, A Genge, JS Mora, KL van den Berg, V Drory, W Robberecht
A double blind, nulti-national, placebo controlled trial of talampanel in amyotrophic lateral sclerosis: study design and subject baseline characteristics
Amyotr. Later. Scler., Vol. 10, Suppl. 1, 2009 (p. 72)
82. B Nefussy, J Hirsch, M Cudkowicz, V Drory
Different effect of statins on the functional decline of men and women with amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 10, Suppl. 1, 2009 (p. 139-140)
83. D Keizman, M Ish-Shalom, S Berliner, N Maimon, Y Vered, I Artamonov, B Nefussy, VE Drory
Low serum uric acid concentration in ALS. A link to oxidative stress-related mechanisms
Eur. J. Neurol., Vol. 16, Suppl. 3, 2009 (p.215)
84. VE Drory, D Gross, I Artmann, SC Blumen
An unusual presentation of hereditary neuropathy with liability to pressure palsies with lower limb hyperreflexia and respiratory muscle weakness in two sisters
J. Neurol., Vol. 257, Suppl. 1, 2010 (pp. S40-S41)
85. SC Blumen, A Kesler, N Blumen, VE Drory, M Gurevich, S Shalev, I Braverman, RL
Carasso, P Nisipeanu, B Brais
Oculopharyngeal muscular dystrophy among Bulgarian Jews. A new cluster?
J. Neurol., Vol. 257, Suppl. 1, 2010 (pp. S175-S176)
86. B Kandinov, A Korczyn, R Rabinowitz, B Nefussy, V Drory
Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis
Amyotr. Later. Scler., Vol. 11, Suppl. 1, 2010 (p. 82)
87. D Ben Bashat, M Artzi, R Tarrasch, O Aizenstein, B Nefussy, I Artmann, VE Drory
A potential tool for the diagnosis of amyotrophic lateral sclerosis based on diffusion tensor imaging
J. Neurol., Vol. 258, Suppl. 1, 2011 (p. 79)
E. Items in encyclopedias
1. 3 items for Israeli Medical Encyclopedia
F. Books edited
1. Guest editor: Treatment of amyotrophic lateral sclerosis: insights into the future. J. Neurol. Suppl., 2000
G. Other publications
1. VE Drory
Laboratory reference for clinical neurophysiology (Book review)
Harefuah, Vol 124, p. 387, 1993 (p. 387)
2. Ludolph AC, Drory VE
Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface
J Neurol, Vol 247 (Suppl 6) (p. 1)
3. VE Drory
טרשת אמיוטרופית צידית
מחלות נאורולוגיות, קבוצת אאורורה, 2002 (pp. 59-61)
4. VE Drory
השמוש המושכל בבדיקות אלקטרומיוגרפיות ובתחום הנאורופיזיולוגיה הקלינית
מחלות נאורולוגיות, קבוצת אאורורה, 2002 (pp. 67-69)
5. B Nefussy, I Artmonov, VE Drory
חדושים בתורשה שלamyotrophic lateral sclerosis ומחלות אחרות של תאי עצב מוטוריים
Israeli J Neurol, 2006 (pp. 3-8)
6. H Gotschal, T Gurevich, VE Drory, Y Segev, AD Korczyn
שתוק מבודד של העצב ההיפוגלוסלי עקב שאת מסוג glomus jugulare
Medicine Neurology 2006 (p. 14)
7. VE Drory
טרשת אמיוטרופית צידית
Medical 2006 (pp. 80-83)
8. Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, Traynor BJ, EURALS Consortium
The epidemiology of ALS and the role of population-based registries
Biochim Biophys Acta, Vol. 1762, 2006 (pp. 1150-1157)
9. N Tihmanovich, VE Drory
הטפול בכאב הנאורופטי
The Pharma, 2007 (pp. 24-26)
10. L Pollak, E Rosenberg, VE Drory
איש מבוגר עם שיתוק בולברי, הפרעות הליכה וצניחת עפעפיים
Medicine Neurology 2007 (p. 9)
11. RAC Hughes, P Donofrio, V Bril, MC Dalakas, C Deng, K Hanna, HP Hartung, N Latov, ISJ Merkies, PA van Doorn, ICE Study Group
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomized placebo-controlled trial
Lancet Neurol., Vol. 7, 2008 (pp. 136-144)
12. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, Swingler RJ, Beghi E, for EURALS
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
J Neurol Neurosurg Psychiatry, Vol. 79, 2008 (pp. 6-11)
13. The ALS Untangled group
ALS Untangled update 1: investigating a bug (Lyme disease) and a drug (Iplex) on behalf of people with ALS
Amyotroph Lateral Scler, 2009, Vol. 10 (pp. 248-250)
14. VE Drory, B Nefussy
Low uric acid levels in serum of patients with ALS (response to letter to the editor)
J Neurol Sci, 2009, Vol. 287 (p. 295)
15. V Bril, H Katzberg, P Donofrio, M Banach, MC Dalakas, C Deng, K Hanna, HP Hartung, RAC Hughes, N Latov, ISJ Merkies, PA van Doorn, ICE Investigators
Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV
Muscle Nerve, Vol. 39, 2009 (pp.448-455)
16. ISJ Merkies, V Bril, C Dalakas, C Deng, P Donofrio, K Hanna, HP Hartung, RAC Hughes, N Latov, PA van Doorn, ICE Study Group
Health-related quality-of-life improvements in CIDP with immune globulin IV 10%. The ICE study
Neurology, Vol. 72, 2009 (pp. 1337-1344)
17. AD Korczyn, VE Drory
Smoking and ALS (Letter to the editor)
Ann Neurol, Vol. 67, 2010 (p. 694)
Prognostic factors in ALS: a critical review
Amyotroph Lateral Scler, 2009, Vol. 10 (pp. 310-323)
19. The ALS Untangled group
ALS Untangled update 2: Investigating the Hickey wellness center
Amyotroph Lateral Scler, 2009, Vol. 10 (pp. 490-491)
20. The ALS Untangled group
ALS Untangled update 3: Investigating stem cells transplants at the Hospital San Jose Tecnologico de Monterrey
Amyotroph Lateral Scler, 2010, Vol. 11 (pp. 248-249)
21. The ALS Untangled group
ALS Untangled update 4: Investigating the XCell-Center
Amyotroph Lateral Scler 2010, Vol. 11 (pp. 337-338)
22. N Latov, C Deng, MC Dalakas, V Bril, P Donofrio, K Hanna, HP Hartung, RAC Hughes, ISJ Merkies, PA van Doorn, for the ICE Study Group
Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
Arch Neurol 2010, Vol 67 (pp. E1-6)
23. The ALS Untangled group
ALS Untangled update 5: Investigating the Stowe/Morales ALS Protocol
Amyotroph Lateral Scler, 2010, Vol. 11 (pp. 414-416)
24. PD Donofrio, V Bril, MC Dalakas, C Deng, K Hanna, HP Hartung, R Hughes, N Latov, I Merkies, P van Doorn, ICE Study Group
Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy
Arch Neurol 2010, Vol. 67 (pp. 1082-1088)
25. V Bril, M Banach, MC Dalakas, C Deng, P Donofrio, K Hanna, HP Hartung, RAC Hughes, H Katzberg, N Latov, ISJ Merkies, PA van Doorn, the ICE Study Group
Electrophysiological correlations with clinical outcomes in CIDP.
Muscle Nerve 2010, Vol. 42 (pp. 492-497)
26. The ALS Untangled group
ALS Untangled update 6: Investigating Marty Murray's Method
Amyotroph Lateral Scler, 2010, Vol. 11 (pp. 494-496)
27. A Abraham, VE Drory
נוירופתיה סוכרתית
Medicine (Internal Medicine) 2010 (p. 30-34)
28. ISJ Merkies, RAC Hughes, P Donofrio, V Bril, MC Dalakas, K Hanna, HP Hartung, N Latov, PA van Doorn, C Deng, ICE Study Group
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study
J Periph Nerv Syst, 2010, Vol. 15 (pp. 208-215)
29. The ALS Untangled group
ALS Untangled update 7: Investigating hyperimmune goat serum (Aimspro) for ALS
Amyotroph Lateral Scler, 2010, Vol. 11 (pp. 571-573)
30. The ALS Untangled group
ALS Untangled update 8: Low dose naltrexone for ALS
Amyotroph Lateral Scler, 2011, Vol. 12 (pp. 76-78)
31. The ALS Untangled group
ALS Untangled update 9: Blue-green algae (Spirulina) for ALS
Amyotroph Lateral Scler, 2011, Vol. 12 (pp. 153-155)
32. The ALS Untangled group
ALS Untangled update 10: Luteolin and Lutimax
Amyotroph Lateral Scler, 2011, Vol. 12 (pp. 235-237)
33. E Beghi, A Chio, P Couratier, J Esteban, O Hardiman, G Logroscino, A Millul, D Mitchell, PM Preux, E Pupillo, Z Stevic, R Swingler, BJ Traynor, LH van den Berg, JH Veldink, S Zoccolella, EURALS
The epidemiology and treatment of ALS: focus on heterogeneity of the disease and critical appraisal of therapeutic trials
Amyotroph Lateral Scler, 2011, Vol. 12 (pp. 1-10)
34. The ALS Untangled group
ALS Untangled update 11: Nu Tech Mediworld
Amyotroph Lateral Scler, 2011, Vol. 12 (pp. 309-311)
35. B Nefussy, VE Drory
קוצב סרעפת. טכנולוגיה חדשה למניעת אי ספיקה נשימתית בנפגעי חוט שדרה ובחולים עם טרשת אמיוטרופית צידית
Journal of the Israeli Neurological Association 2011, Vol. 6 (pp. 17-19)
36. The ALS Untangled group
ALS Untangled update 12: Dean Kraft, Energy Healer
Amyotroph Lateral Scler, 2011, Vol. 12 (pp. 389-391)
37. The ALS Untangled group
ALS Untangled update 13: Bee venom
Amyotroph Lateral Scler, 2011, Vol. 12 (pp. 471-472)
38. The ALS Untangled group
ALS Untangled update 14: Mototab
Amyotroph Lateral Scler, 2012, Vol. 13 (pp. 161-164)
39. The ALS Untangled group
ALS Untangled update 15: Coconut oil
Amyotroph Lateral Scler, 2012, Vol. 13 (pp. 328-330)
40. The ALS Untangled group
ALS Untangled update 16: Cannabis
Amyotroph Lateral Scler, 2012, Vol. 13 (pp. 400-404)
41. The ALS Untangled group
ALS Untangled update 17: "When ALS is Lyme"
Amyotroph Lateral Scler, 2012, Vol. 13 (pp. 487-491)
42. The ALS Untangled group
ALS Untangled update 18: "Apoaequorin (Prevagen)"
Amyotroph Lateral Scler Frontotemp Degener, 2013, Vol. 14 (pp. 78-79)
43. The ALS Untangled group
ALS Untangled update 19: Sodium chlorite
Amyotroph Lateral Scler Frontotemp Degener, 2013, Vol. 14 (pp.236-238)
44. The ALS Untangled group
ALS Untangled update 20: The Deanna protocol
Amyotroph Lateral Scler Frontotemp Degener, 2013, Vol. 14 (pp. 319-323)
45. VE Drory
שמוש בקנביס למטרות רפואיות - ALS
Journal of the Israeli Neurological Association 2013, Vol. 13 (p. 34)
46. The ALS Untangled group
ALS Untangled update 21: Fecal transplants
Amyotroph Lateral Scler Frontotemp Degener, 2013, Vol. 14 (pp. 482-485)
47. The ALS Untangled group
ALS Untangled update 22: Propofol
Amyotroph Lateral Scler Frontotemp Degener, 2013, Vol. 14 (pp. 640-642)
48. The ALS Untangled group
ALS Untangled update 23: The Rife Machine and retroviruses
Amyotroph Lateral Scler Frontotemp Degener, 2014, Vol. 15 (pp. 157-159)
49. The ALS Untangled group
ALS Untangled update 24: Vitamin D
Amyotroph Lateral Scler Frontotemp Degener, 2014, Vol. 15 (pp. 318-320)
50. The ALS Untangled group
ALS Untangled update 25: Ursodiol
Amyotroph Lateral Scler Frontotemp Degener, 2014, Vol. 15 (pp. 475-478)
51. The ALS Untangled group
ALS Untangled update 26: Lunasin
Amyotroph Lateral Scler Frontotemp Degener, 2014, Vol. 15 (pp. 622-626)
